Dr. Lee Reichman responds to TB and Haiti crisis

Last week, a story in the NY Times explored the emerging threat of drug-resistant TB spreading in the aftermath of the tragic earthquake in Haiti.

On Sunday, Feb 14, the NY Times published in a letter to editor from Dr. Lee Reichman, MD, MPH (Professor and Executive Director, UMDNJ-New Jersey Medical School Global Tuberculosis Institute) in response to the original article. Dr. Reichman provides greater context to drug-resistant TB as a global health threat, and articulated the important role new TB drugs will play in controlling and preventing drug-resistant TB.

” But the point that urgently needs to be raised is that these multiple and extensively drug-resistant TB strains are already increasing globally even in the absence of major disasters.

Propagation of drug-resistant strains always occurs because of neglected or inappropriate basic TB control practices. Obviously, these situations are magnified by a major disaster such as you describe in Haiti. But these can be fixed by political will, resolve and financing.”

Click here to read the full response

What suggestions do you have regarding the global threat of TB? Of drug resistant and multi-drug resistant TB? Share your thoughts and comments below.

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...